Efficacy and safety of stapokibart (CM310) in adults with moderate-to-severe atopic dermatitis: a multicenter, randomized, double-blind, placebo-controlled phase 3 trial
收藏NIAID Data Ecosystem2026-05-02 收录
下载链接：
https://data.mendeley.com/datasets/27f6zxm563
下载链接
链接失效反馈官方服务：
资源简介：
Supplementary Materials for "Efficacy and safety of stapokibart (CM310) in adults with moderate-to-severe atopic dermatitis: a multicenter, randomized, double-blind, placebo-controlled phase 3 trial".
创建时间：
2024-07-12
